Archives
-
Muscle BDNF and Early NMJ Postsynaptic Assembly
2026-09-16
This study shows that muscle-derived BDNF is not merely a diffusible trophic factor: it is transported to podosome-like structures, released locally in an activity- and calcium-dependent manner, and proteolytically processed to regulate early acetylcholine receptor assembly. Evidence from Xenopus muscle cultures and muscle-specific BDNF knockout mice connects BDNF trafficking and maturation with both aneural and nerve-induced neuromuscular junction development.
-
iTBS in SCA3 Mice: Motor and Molecular Effects
2026-09-16
A 2026 study compared intermittent and continuous theta-burst stimulation in SCA3/MJD transgenic mice and found that iTBS produced broader improvements in motor coordination, cerebellar pathology, neuroinflammatory markers, and autophagy-related proteins. The findings support paradigm-specific neuromodulation as a testable approach for SCA3 biology, while the short treatment period and marker-based design limit conclusions about long-term disease modification.
-
From m6A Biology to Better UC Immunoblots
2026-09-15
A translational framework for connecting METTL14–DHRS4-AS1–miR-206/A3AR biology in ulcerative colitis with more sensitive, reproducible immunoblotting using the ECL Chemiluminescent Substrate Detection Kit (Hypersensitive).
-
GM 6001 (Galardin): Mechanistic Assay Guide
2026-09-15
GM 6001 (Galardin) is a nanomolar broad-spectrum MMP inhibitor for separating extracellular matrix proteolysis from cell-intrinsic signaling. This guide applies it as a mechanistic control in tissue repair, vascular, EGFR, and renal cancer assay design.
-
Mitomycin C: From DNA Damage to Translation
2026-09-14
A mechanistic and translational framework for using Mitomycin C as an antitumor antibiotic, DNA replication inhibitor, and apoptosis-modeling tool in cancer research.
-
CaP-Pickering Emulsions for mRNA Cancer Vaccines
2026-09-14
The reference study develops a calcium phosphate nanoparticle-stabilized water-in-oil-in-water Pickering emulsion, CaP-PME, as a non-LNP platform for cancer-vaccine mRNA delivery. Its importance lies in combining cytosolic mRNA transport with dendritic-cell activation and natural-killer-cell engagement, producing stronger antitumor responses in E.G7 and B16-OVA models.
-
EZ Cap™ Cre mRNA (m1Ψ): Assay Design Guide
2026-09-13
Learn how EZ Cap™ Cre mRNA (m1Ψ) converts transient Cre expression into a controllable recombination assay. This guide connects RNA engineering, loxP biology, delivery constraints, and practical validation choices.
-
Xenopus Pluripotency Network Rewired by Hybridization
2026-09-12
Phelps et al. show that hybridization reshaped the early pluripotency network of allotetraploid Xenopus laevis through asymmetric regulation of its L and S subgenomes. Combining transcriptional inhibition, homeolog-resolved RNA-seq, chromatin profiling, and comparative genomics, the study finds that divergent regulatory architecture coexists with conserved total gene dosage.
-
Batimastat (BB-94) for MMP Assays and BDNF
2026-09-11
Use Batimastat (BB-94) to separate extracellular MMP-dependent proteolysis from intracellular processing in neuromuscular synapse and tumor experiments. This workflow combines biochemical validation, compartment-aware cell assays, and carefully controlled translational models without treating broad MMP inhibition as proof of a single-enzyme mechanism.
-
MMP-2-Responsive Peptide Therapy in Breast Cancer
2026-09-11
The reference study developed a self-assembling peptide nanoparticle that responds to MMP-2 by changing morphology while co-delivering doxorubicin and indomethacin. This design improved tumor-cell retention, promoted immunogenic cell death, reduced tumor-associated inflammation, and strengthened antitumor immune activity in breast cancer models.
-
Apigenin: From HDAC Assays to Network Medicine
2026-09-10
Apigenin research connects HDAC-associated malignant mesothelioma biology with network-informed neuroprotection. This article translates the evidence into practical assay decisions, emphasizing dose selection, orthogonal readouts, solubility controls, and the limits of cross-domain interpretation.
-
SB-3CT Workflows for MMP-9 and ECM Research
2026-09-10
SB-3CT is a mechanism-based gelatinase inhibitor for separating MMP-2/MMP-9 biology from broader matrix metalloproteinase effects. This practical guide connects tumor invasion, angiogenesis inhibition, cerebral ischemia, and perineuronal-net assays while emphasizing controls, concentration design, and interpretation limits.
-
CAFs, Fatty Acids, and Lipid Rafts in Oral Cancer
2026-09-09
The reference study identifies a metabolic communication axis in which cancer-associated fibroblast-derived free fatty acids support oral squamous cell carcinoma by promoting lipid raft formation and PI3K/AKT signaling. Its integrated omics, biochemical, imaging, and functional assays connect stromal lipid metabolism with membrane organization and malignant behavior, while also highlighting questions about lipid specificity and in vivo transferability.
-
Direct Mouse Genotyping Kit Plus for Lineage Studies
2026-09-09
The Direct Mouse Genotyping Kit Plus supports rapid PCR-based mouse genotyping while helping researchers interpret lineage-tracing and macrophage plasticity experiments. Learn how direct lysate workflows strengthen transgene detection, knockout validation, and assay design without confusing genotype with cell state.
-
ARL4C, FLS Proliferation, and RA Progression
2026-09-08
The reference study integrates single-cell and bulk RNA sequencing with cellular, co-culture, and collagen-induced arthritis experiments to identify ARL4C as a driver of rheumatoid arthritis synoviocyte activation. Its findings connect ARL4C-dependent fibroblast-like synoviocyte proliferation with macrophage polarization, synovial inflammation, and cartilage damage, while also suggesting a framework for complementary S-phase validation.